Deloitte expands life sciences solutions suite

To expand its suite of information technology quality and compliance solutions for life sciences organizations, Deloitte has acquired QSpace, a cloud-based, globally scalable, end-to-end automated, validation lifecycle management system (VLMS) from Archimedis Healthcare Private Limited (Archimedis), a family owned pharmaceutical manufacturer based in India, the company said.

The deal closed Aug. 24, 2018.

Launched in March 2017, QSpace is a VLMS that is designed to address IT quality and compliance, computerized system validation and Good X Practice requirements by digitizing the end-to-end validation process for IT systems in life sciences companies subject to US and global regulatory requirements.

Unlike many other solutions, QSpace integrates a number of aspects of IT quality and compliance within a single risk-based platform customized for life sciences organizations. It uses lean processes and system-induced controls to help reduce human errors and create greater enterprise-wide collaboration opportunities. QSpace´s powerful analytics provide near real-time insights into critical performance indicators across the validation lifecycle, creating greater efficiencies that can help reduce compliance costs.

The subsidiaries of Deloitte LLP provide industry-leading audit, consulting, tax and advisory services to many of the world´s most admired brands, including more than 85 percent of the Fortune 500 and more than 6,000 private and middle market companies.